Finance

Lists
001065:KRX
JW Pharmaceutical(1P) Pref Shs
₩21 300,00
-0,70%
(-150,00) 1D
15 Okt., 15:30:00 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001065...
Open
₩21 350
High
₩21 350
Low
₩21 300
Mkt. cap
585,28 mjd
Avg. vol.
123,00
Volume
2,00
Dividend
3,05%
Quarterly dividend
â‚©162
Ex-dividend date
27 Des. 2023
P/E ratio
5,08
52-wk high
₩30 300
52-wk low
₩19 710
EPS
₩4 193
Shares outstanding
341,95 k
No. of employees
1 k
Open
₩21 350
High
₩21 350
Low
₩21 300
Mkt. cap
585,28 mjd
Avg. vol.
123,00
Volume
2,00
Dividend
3,05%
Quarterly dividend
â‚©162
Ex-dividend date
27 Des. 2023
P/E ratio
5,08
52-wk high
₩30 300
52-wk low
₩19 710
EPS
₩4 193
Shares outstanding
341,95 k
No. of employees
1 k
News stories
From web sources and news partners
About JW Pharmaceutical(1P) Pref Shs
CEOLee, Kyung Ha
Employees1,05 k
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
200,02 mjd
198,94 mjd
199,88 mjd
222,02 mjd
Cost of goods sold
105,39 mjd
109,09 mjd
101,43 mjd
116,73 mjd
Cost of revenue
105,39 mjd
109,09 mjd
101,43 mjd
116,73 mjd
Research and development expenses
7,33 mjd
15,27 mjd
9,38 mjd
11,86 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 mjd
60,42 mjd
55,91 mjd
59,90 mjd
Operating expense
62,60 mjd
80,98 mjd
64,88 mjd
71,95 mjd
Total operating expenses
167,99 mjd
190,07 mjd
166,31 mjd
188,68 mjd
Operating income
32,03 mjd
8,87 mjd
33,58 mjd
33,34 mjd
Other non operating income
-4,64 mjd
8,03 mjd
1,21 mjd
835,27 m
EBT including unusual items
27,85 mjd
17,49 mjd
35,20 mjd
34,76 mjd
EBT excluding unusual items
27,85 mjd
15,96 mjd
35,20 mjd
34,76 mjd
Income tax expense
-2,74 mjd
2,18 mjd
7,72 mjd
6,86 mjd
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 mjd
15,32 mjd
27,48 mjd
27,89 mjd
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 k
-
-
-
Interest and investment income
-
3,34 mjd
-
-
Interest expense
-
-4,42 mjd
-
-
Net interest expenses
-
-1,09 mjd
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 mjd
13,65 mjd
38,56 mjd
38,37 mjd
Gain or loss from assets sale
5,12 m
3,00 k
-10,00 m
3,00 k
AI content may include mistakes. Learn more
Google-programme